Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 5, 1997, Pages 1007-1011

  Tarnawski, Rafal ^a   Skladowski, Krzysztof ^a   Maciejewski, Boguslaw ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Hemoglobin; Local tumor control; Performance index1 Laryngeal cancer; Tumor control probability

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEMOGLOBIN A; HUMANS; LARYNGEAL NEOPLASMS; LIKELIHOOD FUNCTIONS; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0030758766     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00308-8     Document Type: Article

References (15)

1. Bentzen, S. M. Quantitative clinical radiobiology. Acta Oncol. 32:259-275; 1993.
2. Bentzen, S. M.; Johansen, L. V.; Overgaard, J.; Thames, H. D. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int. J. Radiat. Oncol. Biol. Phys. 20:1197-1206; 1991.
3. BMDP/386 Dynamic BMDP Statistical Software Inc. 1992 License No. 169-7072.
4. Dixon, W. J., ed. BMDP statistical software manual, vol. 2. Berkeley: BMDP Statistical Software Inc.; 1992.
5. Fazekas, J. T.; Scott, C.; Marcial, V.; Davis, L. W.; Wasserman, T.; Cooper, J. S. The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on RTOG trial #79-15. Int. J. Radiat. Oncol. Biol. Phys. 17:1177-1181; 1989.
6. Hermanek, P.; Sobin, L. H., eds. TNM classification of malignant tumours. Berlin: Springer Verlag; 1992.
7. Overgaard, J. Sensitization of hypoxix tumour cells-clinical experience. Int. J. Radiat. Biol. 56:801-811; 1989.
8. Overgaard, J.; Horsman, M. R. Overcoming hypoxic cell radioresistance. In: Steel, G. G. eds. Basic clinical radiobiology. London: Edward Arnold Publ.; 1993:168.
9. Overgaard, J.; Sand Hansen, H.; Andersen, A. P.; Hjelm-Handsen, M.; Jorgensen, K.; Snadberg, E., Berthelsen A., Jensen, R. H., Pedersen, M. Misonidasole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx. Report from DAHANCA 2 study. Int. J. Radiat Oncol. Biol. Phys. 16:1065-1068; 1989.
10. Peters, L. J.; Ang, K. K. The role of altered fractionation in Head and Neck Cancers. Semin. Radiat. Oncol. 2:180-194; 1992.
11. Peters, L. J.; Brock W. A.; Chapman J. D.; Wilson, G. Predictive assays of tumor radiocurability. Am. J. Clin. Oncol. 11:275-287; 1988.
12. Skladowski, K.; Law, M. G.; Maciejewski, B.; Steel, G. G. Planned and unplanned gaps in radiotherapy: The importance of gap position and gap duration. Radiother. Oncol. 30:109-120; 1994.
13. Thames, H. D.; Rozell, M. E.; Tucker, S. L.; Ang, K. K.; Fisher, D. R.; Travis, E. L. Direct analysis of quantal radiation response data. Int. J. Radiat. Biol. 49:999-1009; 1986.
14. van-Acht, M. J.; Hermans, J.; Boks, D. E.; Leer, J. W. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother. Oncol. 323:229-235; 1992
15. Weber, R. S.; Callender D. L. Laryngeal concervation surgery. Semin. Radiat. Oncol. 2:149-157; 1992.